Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The metastasis of human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSC) is associated with poor prognosis, yet the regulatory mechanisms remain unclear. In this study, we developed a metastasis prediction model using the transcriptomes of 333 HPV-negative HNSC tumor samples, representing one of the largest HPV-negative HNSC sample sets to date. Our model, which leverages miRNA-centered regulatory networks extended by regulome data, showed superior predictive performance with an AUC of 0.805 compared to existing metastasis-related biomarkers. We identified three key miRNAs in our model with significant differential expression in metastatic patients. Notably, miR-27b was downregulated and its target gene FN1 was overexpressed, leading to activation of the cell adhesion pathway. Single-cell RNA-seq analysis confirmed FN1 overexpression specifically in the malignant cells of metastasis patients with HPV-negative HNSC. In vitro, miR-27b was found to reduce metastatic potential by negatively regulating FN1 expression at the translational level. These findings suggest FN1, driven by miR-27b, as a potential driver of metastasis in HPV-negative HNSC, offering new avenues for biomarker development and targeted therapeutic strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316908PMC
http://dx.doi.org/10.1038/s41598-025-08646-3DOI Listing

Publication Analysis

Top Keywords

hpv-negative hnsc
16
regulatory networks
8
head neck
8
fn1
5
hpv-negative
5
hnsc
5
mirna centered
4
centered regulatory
4
networks identify
4
identify fn1
4

Similar Publications

The metastasis of human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSC) is associated with poor prognosis, yet the regulatory mechanisms remain unclear. In this study, we developed a metastasis prediction model using the transcriptomes of 333 HPV-negative HNSC tumor samples, representing one of the largest HPV-negative HNSC sample sets to date. Our model, which leverages miRNA-centered regulatory networks extended by regulome data, showed superior predictive performance with an AUC of 0.

View Article and Find Full Text PDF

Head and neck squamous cell carcinoma (HNSC) is a prevalent malignancy, with HPV-negative tumors exhibiting aggressive behavior and poor prognosis. Understanding the intricate interactions within the tumor microenvironment (TME) is crucial for improving prognostic models and identifying therapeutic targets. Using BulkSignalR, we identified ligand-receptor interactions in HPV-negative TCGA-HNSC cohort (n = 395).

View Article and Find Full Text PDF

Prior to the next generation sequencing and characterization of the tumor genome landscape, mutations in the SWI/SNF chromatin remodeling complex and the KEAP1-NRF2 signaling pathway were underappreciated. While these two classes of mutations appeared to independently contribute to tumor development, recent reports have demonstrated a mechanistic link between these two regulatory mechanisms in specific cancer types and cell models. In this work, we expand upon these data by exploring the relationship between mutations in BAF and PBAF subunits of the SWI/SNF complex and activation of NRF2 signal transduction across many cancer types.

View Article and Find Full Text PDF

Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis.

Cureus

December 2023

Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Background Head and neck squamous cell carcinoma (HNSCC) is a prominent global cancer that manifests across diverse sites such as the oral cavity, oropharynx, and larynx. Human papillomavirus (HPV) infection and genetic alterations contribute to HNSCC development. Objective To investigate the complex role of breast carcinoma amplified sequence (BCAS3) in HNSCC pathogenesis.

View Article and Find Full Text PDF

DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma.

J Stomatol Oral Maxillofac Surg

September 2024

Molecular Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India. Electronic address:

Background/purpose: Dynein Cytoplasmic 1 Intermediate Chain 1 (DYNC1I1) is a crucial cytoplasmic dynein binding component, its high expression levels are associated with malignant progression and poor survival in different types of cancer; however, the oncogenic role of DYNC1I1 in Head and neck squamous cell carcinomas (HNSCC) remains to be elucidated. In our present study, we aimed to explore the potential role of DYNC1I1 expression in the tumorigenesis of HNSCC and the shaping of the immune microenvironment.

Materials And Methods: The expression levels of DYNC1I1 were analyzed in The Cancer Genome Atlas Head-Neck Squamous Cell Carcinoma (TCGA-HNSC) dataset, and then real-time quantitative polymerase chain reaction (RT-qPCR) was used to validate the DYNC1I1 expression in oral squamous cell carcinoma (OSCC) tumor samples, one of the major types of HNSCC.

View Article and Find Full Text PDF